Balaji Amines: Testing Long-Term Logarithmic Trendline with ₹1,100+ Cr Capex in Place

Balaji Amines (***** is retesting a multi-year logarithmic support zone—previously seen in 2014 and 2020, each followed by large multi-year moves. What makes this test significant is the visible alignment with fundamental expansion: 🧾 FY20–FY25 Financial Trends: Capex (Fixed Assets + CWIP): ₹619 Cr → ₹1,240 Cr Borrowings: ₹260 Cr → ₹11 Cr Reserves: ₹652 Cr → ₹1,839 Cr Assets: Doubled from ₹1,113 Cr → ₹2,252 Cr This expansion has been funded via internal accruals, not debt or dilution. 🔧 FY26E Catalysts: Expected Revenue: ₹3,900–₹4,200 Cr PAT: ₹430 Cr EPS: ₹133 Scaled volumes from DME, DMC, NBPT, and methylamines across EV, agro, and fuel blending segments 🎯 Entry & First Target: Entry Zone: ₹1,400–₹1,500 Initial Target (12–24 months): ₹2,800–₹3,900 ↪ Based on earnings visibility and historical technical behavior 📈 Weekly log chart attached shows the same trendline now being tested for the third time in 10+ years. 📢 Disclaimer: This post is for informational purposes only. Nothing herein constitutes a buy or sell recommendation. I may or may not be holding a position in the stock mentioned. 🧑‍💼 Rajneesh Sharma is a SEBI-registered Research Analyst (INH000020332). 📄 Investments are subject to market risks. Read all related documents carefully before investing.